Skip to main content

Animations

MJFF Publications

1541 - 1550 of 8571 Results
Title
Year
  • Year
  • 2019
  • 2023
  • 2022
  • 2015
  • 2020
  • 2020
  • 2024
  • 2017
  • 2016
  • 2025
  • Summary Details
    RESTRICTED
    Title: Patient-Centered Clinical Trial Design: A Case Study in Parkinson’s Disease (P2.8-008)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-008
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Imaging-based DBS programming help: Does it help?
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105362
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson’s disease
    Journal Name: Molecular Therapy - Nucleic Acids
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.omtn.2022.02.007
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Constructing de Novo H2O2 Signaling via Induced Protein Proximity
    Journal Name: ACS Chemical Biology
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschembio.5b00170
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Cortical disinhibition in Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awaa274
    Citation Count: 68
  • Summary Details
    RESTRICTED
    Title: Validation of a Reversed Phase UPLC-MS/MS Method to Determine Dopamine Metabolites and Oxidation Intermediates in Neuronal Differentiated SH-SY5Y Cells and Brain Tissue
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.0c00336
    Best OA location URL:
    Citation Count: 13
  • Summary Details
    RESTRICTED
    Title: Dual-task gait has prognostic value for cognitive decline in Parkinson’s disease
    Journal Name: Journal of Clinical Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jocn.2024.06.006
    Best OA location URL:
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Parkinson's disease prevalence in Fabry disease: A survey study
    Journal Name: Molecular Genetics and Metabolism Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.ymgmr.2017.10.013
    Citation Count: 39
  • Summary Details
    RESTRICTED
    Title: Lewy bodies are incidental in essential tremor
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.02.025
    Best OA location URL:
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Motor and nonmotor features of p.A53T alpha-synuclein PD vs idiopathic PD: longitudinal data from the PPMI study
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00415-024-12836-w
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.